Tyr1068-phosphorylated epidermal growth factor receptor (EGFR) predicts cancer stem cell targeting by erlotinib in preclinical models of wild-type EGFR lung cancer

G. Sette, Giovanni Sette, V. Salvati, Valentina Salvati, M. Mottolese, P. Visca, E. Gallo, K. Fecchi, E. Pilozzi, E. Duranti, E. Policicchio, M. Tartaglia, Marco Tartaglia, M. Milella, Ruggero De Maria Marchiano, A. Eramo

Research output: Contribution to journal › Article › peer-review

25 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Tyr1068-phosphorylated epidermal growth factor receptor (EGFR) predicts cancer stem cell targeting by erlotinib in preclinical models of wild-type EGFR lung cancer'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science